Published in Neuropsychology on April 01, 1999
Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev (2009) 2.86
Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clin Infect Dis (2005) 1.07
HIV and recent illicit drug use interact to affect verbal memory in women. J Acquir Immune Defic Syndr (2013) 0.95
Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study. Neuropsychologia (2009) 0.94
The relationship between computer experience and computerized cognitive test performance among older adults. J Gerontol B Psychol Sci Soc Sci (2012) 0.91
Callosal Compromise Differentially Affects Conflict Processing and Attentional Allocation in Alcoholism, HIV, and Their Comorbidity. Brain Imaging Behav (2008) 0.91
Psychiatric and neurophysiological predictors of obesity in HIV/AIDS. Psychophysiology (2008) 0.88
Disruption of emotion and conflict processing in HIV infection with and without alcoholism comorbidity. J Int Neuropsychol Soc (2011) 0.88
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behav Brain Res (2012) 0.86
Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc (2013) 0.83
A family history of psychopathology modifies the decrement in cognitive control among patients with HIV/AIDS. Brain Cogn (2008) 0.82
Neuropsychological Dysfunction among HIV Infected Drug Abusers. Am J Infect Dis (2006) 0.79
Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention - A Comparison with Parkinson's Disease. Neuropsychol Rev (2015) 0.78
Sustained attention deficits among HIV-positive individuals with comorbid bipolar disorder. J Neuropsychiatry Clin Neurosci (2012) 0.76
Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1. J Neurovirol (2016) 0.75
Testing a Computerized Cognitive Training Protocol in Adults Aging With HIV-Associated Neurocognitive Disorders: Randomized Controlled Trial Rationale and Protocol. JMIR Res Protoc (2017) 0.75
Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology (2002) 4.67
In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob Agents Chemother (1989) 3.17
Neurocognitive functioning of adolescents: effects of protracted alcohol use. Alcohol Clin Exp Res (2000) 3.16
In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile. Antimicrob Agents Chemother (1991) 2.23
Episodic and semantic memory: a comparison of amnesic and demented patients. J Clin Exp Neuropsychol (1987) 1.85
Selective utilization of DNA probes for identification of Mycobacterium species on the basis of cord formation in primary BACTEC 12B cultures. J Clin Microbiol (1995) 1.72
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease. J Infect Dis (1991) 1.72
Pupillary and reaction time measures of sustained processing of negative information in depression. Biol Psychiatry (2001) 1.51
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test. J Clin Microbiol (1988) 1.44
A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1988) 1.41
Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun (2012) 1.40
Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae. Antimicrob Agents Chemother (1992) 1.37
Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol (2001) 1.35
Methylphenidate improves HIV-1-associated cognitive slowing. J Neuropsychiatry Clin Neurosci (2001) 1.23
Activity of temafloxacin against respiratory pathogens. Antimicrob Agents Chemother (1991) 1.16
Verbal memory deficits associated with major affective disorders: a comparison of unipolar and bipolar patients. J Affect Disord (1987) 1.14
Brain activation and pupil response during covert performance of the Stroop Color Word task. J Int Neuropsychol Soc (1999) 1.11
Pathophysiology of primary meningococcal pericarditis associated with Neisseria meningitidis group C. A case report and review of the literature. Diagn Microbiol Infect Dis (1986) 1.08
An assessment of verbal recall, recognition and fluency abilities in patients with Huntington's disease. Cortex (1986) 1.06
Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates. Addict Behav (2007) 1.05
Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams. J Clin Microbiol (1992) 1.04
Comparative in vitro potencies of nine new macrolides. Drugs Exp Clin Res (1988) 1.04
Screening for drug and alcohol abuse among older adults using a modified version of the CAGE. Am J Addict (2001) 1.04
Memory disorders associated with Huntington's disease: verbal recall, verbal recognition and procedural memory. Neuropsychologia (1985) 1.02
Reproducibility of disc susceptibility tests with Haemophilus influenzae. J Antimicrob Chemother (1991) 1.00
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin. J Clin Microbiol (1992) 0.98
Total parenteral nutrition-induced changes in gut mucosal function: atrophy alone is not the issue. Surgery (1992) 0.98
New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance. Antimicrob Agents Chemother (1989) 0.97
The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav (2013) 0.95
Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine. Eur J Clin Microbiol Infect Dis (1993) 0.95
Dual task performance in HIV-1 infection. J Clin Exp Neuropsychol (2000) 0.94
Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. Int J Methods Psychiatr Res (2006) 0.94
Klebsiella neonatal injections: mechanism of broadening aminoglycoside resistance. Antimicrob Agents Chemother (1980) 0.93
Phenelfamycins, a novel complex of elfamycin-type antibiotics. III. Activity in vitro and in a hamster colitis model. J Antibiot (Tokyo) (1989) 0.92
Preparation and in vitro and in vivo evaluation of quinolones with selective activity against gram-positive organisms. J Med Chem (1992) 0.92
Altromycins, novel pluramycin-like antibiotics. I. Taxonomy of the producing organism, fermentation and antibacterial activity. J Antibiot (Tokyo) (1990) 0.91
A randomized controlled pilot study of cognitive behavioral social skills training for older patients with schizophrenia. Schizophr Res (2002) 0.91
Depression predicts procedural but not episodic memory in HIV-1 infection. J Clin Exp Neuropsychol (1998) 0.91
Factor structure of the Alcohol Use Disorders Identification Test (AUDIT) in a mental health clinic sample. J Stud Alcohol (2000) 0.91
Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models. Drugs Exp Clin Res (1988) 0.90
Cognitive/neuropsychological studies of children with a schizophrenic disorder. Schizophr Bull (1994) 0.90
Development of an integrated cognitive-behavioral and social skills training intervention for older patients with schizophrenia. J Psychother Pract Res (2000) 0.90
Differentiation of deception using pupillary responses as an index of cognitive processing. Psychophysiology (2001) 0.90
Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. III. Microbiologic profile. J Antibiot (Tokyo) (1989) 0.90
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam. Eur J Clin Microbiol Infect Dis (1992) 0.88
Priming semantic relations in patients with Huntington's disease. Brain Lang (1988) 0.87
Evidence that therapy works in clinically representative conditions. J Consult Clin Psychol (1997) 0.87
The role of neurocognitive abilities in coping with adolescent relapse to alcohol and drug use. J Stud Alcohol (1999) 0.86
Neonatal Trichosporon beigelii infection: report of a cluster of cases in a neonatal intensive care unit. Pediatr Infect Dis J (1993) 0.86
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam. Eur J Clin Microbiol Infect Dis (1993) 0.86
Low-dose enteral feeding is beneficial during total parenteral nutrition. Am J Surg (1996) 0.85
Endocarditis due to Corynebacterium pseudodiphtheriticum. N Y State J Med (1986) 0.84
Neisseria elongata subsp. elongata, a case of human endocarditis complicated by pseudoaneurysm. J Clin Microbiol (1996) 0.84
Visuospatial and Attentional Abilities Predict Driving Simulator Performance Among Older HIV-infected Adults. Am J Alzheimers Dis Other Demen (2013) 0.84
Liver abscess in Crohn's disease. Am J Gastroenterol (1994) 0.83
In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa. J Antimicrob Chemother (1994) 0.81
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae. Diagn Microbiol Infect Dis (1994) 0.81
Pupillary responses and processing resources on the visual backward masking task. Psychophysiology (2001) 0.80
Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis. Am J Med (1997) 0.80
Positive and negative schizotypal symptoms relate to different aspects of crossover reaction time task performance. Psychiatry Res (1998) 0.79
Effects of schizophrenia and aging on pupillographic measures of working memory. Schizophr Res (1997) 0.79
Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests. J Clin Microbiol (1993) 0.78
Synthesis, antibacterial activities, and pharmacological properties of enantiomers of temafloxacin hydrochloride. J Med Chem (1991) 0.78
Recognition memory span in mildly and moderately demented patients with Alzheimer's disease. J Clin Exp Neuropsychol (1989) 0.78
Ethical issues in psychosocial interventions research involving controls. Ethics Behav (2002) 0.77
Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia. Int Psychogeriatr (2010) 0.77
Coumamidines, new broad spectrum antibiotics of the cinodine type. III. Microbiologic activity of coumamidine gamma 1. J Antibiot (Tokyo) (1989) 0.77
Microbial resistance: novel screens for a contemporary problem. Med Res Rev (1999) 0.77
Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters. Eur J Clin Microbiol Infect Dis (1996) 0.77
Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters. J Clin Microbiol (1993) 0.75
Synthesis and antimicrobial activities of 9(S)-N,N-dimethyl-amino-9-deoxo-10, 11,12,13-tetrahydroniddamycin. J Antibiot (Tokyo) (1991) 0.75
Synthesis and activity of C-21 alkylamino derivatives of (9R)-erythromycylamine. J Antibiot (Tokyo) (1992) 0.75
A characterisation of the peptide transport system in barley seeds. Biochem Soc Trans (1995) 0.75
Synthesis and antibacterial activities of C-21 functionalized derivatives of (9R)-9-amino-9-deoxoerythromycins A and B. J Med Chem (1991) 0.75